{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T23:50:22Z","timestamp":1787615422430,"version":"build-2736575974"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T00:00:00Z","timestamp":1642636800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003808","name":"Hospital Authority","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003808","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005583","name":"Center for Study of Law and Culture, Columbia University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005583","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005407","name":"Food and Health Bureau","doi-asserted-by":"publisher","award":["COVID19F01"],"award-info":[{"award-number":["COVID19F01"]}],"id":[{"id":"10.13039\/501100005407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000276","name":"Department of Health and Social Care","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000276","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003452","name":"Innovation and Technology Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003452","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Western Pacific"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.lanwpc.2022.100393","type":"journal-article","created":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T05:56:25Z","timestamp":1643781385000},"page":"100393","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Herpes zoster related hospitalization after inactivated (CoronaVac) and mRNA (BNT162b2) SARS-CoV-2 vaccination: A self-controlled case series and nested case-control study"],"prefix":"10.1016","volume":"21","author":[{"given":"Eric Yuk Fai","family":"Wan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celine Sze Ling","family":"Chui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa Wai Sei","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent Ka Chun","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9121-1959","authenticated-orcid":false,"given":"Francisco Tsz Tsun","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6895-6071","authenticated-orcid":false,"given":"Carlos King Ho","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther Wai Yin","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4603-6407","authenticated-orcid":false,"given":"Christina Sze Man","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4777-388X","authenticated-orcid":false,"given":"Kathy Sze Man","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael Yuxuan","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie Alessandra","family":"Valkenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph Sriyal Malik","family":"Peiris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph Tsz Kei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin John","family":"Cowling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren M","family":"Ashcroft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan Fan Ngai","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel Matthew","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian Chi Kei","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lanwpc.2022.100393_bib0001","unstructured":"United States Department of Health and Human Services (DHHS), Public Health Service (PHS), Centers for Disease Control (CDC) \/Food and Drug Administration (FDA). Vaccine Adverse Event Reporting System (VAERS) 1990 - 09\/10\/2021, CDC WONDER On-line Database; 2021. http:\/\/wonder.cdc.gov\/vaers.html. Accessed 20 September 2021."},{"key":"10.1016\/j.lanwpc.2022.100393_bib0002","unstructured":"Medicines & Healthcare Products Regulatory Agency. Coronavirus vaccine weekly summary of yellow card reporting; 2021. https:\/\/www.gov.uk\/government\/publications\/coronavirus-covid-19-vaccine-adverse-reactions\/coronavirus-vaccine-summary-of-yellow-card-reporting. Accessed 3 October 2021."},{"key":"10.1016\/j.lanwpc.2022.100393_bib0003","article-title":"Herpes zoster following BNT162b2 mRNA COVID-19 vaccination in patients with autoimmune inflammatory rheumatic diseases: a case series","author":"Furer","year":"2021","journal-title":"Rheumatology"},{"key":"10.1016\/j.lanwpc.2022.100393_bib0004","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jdcr.2021.04.014","article-title":"Varicella-zoster virus reactivation after SARS-CoV-2 BNT162b2 mRNA vaccination: Report of 5 cases","volume":"12","author":"Rodr\u00edguez-Jim\u00e9nez","year":"2021","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.lanwpc.2022.100393_bib0005","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jdcr.2021.05.042","article-title":"Herpes zoster reactivation after mRNA-1273 (Moderna) SARS-CoV-2 vaccination","volume":"15","author":"Channa","year":"2021","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.lanwpc.2022.100393_bib0006","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jdcr.2021.07.011","article-title":"Varicella zoster virus reactivation and mRNA vaccines as a trigger","volume":"15","author":"Llad\u00f3","year":"2021","journal-title":"JAAD Case Rep"},{"issue":"9155","key":"10.1016\/j.lanwpc.2022.100393_bib0007","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0140-6736(99)00623-6","article-title":"Reactivation of herpesvirus infections after vaccinations?","volume":"353","author":"Walter","year":"1999","journal-title":"Lancet"},{"issue":"7264","key":"10.1016\/j.lanwpc.2022.100393_bib0008","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1136\/bmj.321.7264.794","article-title":"Prevalence of postherpetic neuralgia after a first episode of herpes zoster: prospective study with long term follow up","volume":"321","author":"Helgason","year":"2000","journal-title":"BMJ (Clinical research ed)"},{"issue":"11","key":"10.1016\/j.lanwpc.2022.100393_bib0009","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1161\/STROKEAHA.109.562017","article-title":"Increased risk of stroke after a herpes zoster attack","volume":"40","author":"Kang","year":"2009","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.lanwpc.2022.100393_bib0010","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.mayocp.2018.12.025","article-title":"Analysis of vascular event risk after herpes zoster from 2007 to 2014 US insurance claims data","volume":"94","author":"Patterson","year":"2019","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.lanwpc.2022.100393_bib0011","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"issue":"10296","key":"10.1016\/j.lanwpc.2022.100393_bib0012","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0140-6736(21)01429-X","article-title":"Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey","volume":"398","author":"Tanriover","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.lanwpc.2022.100393_bib0013","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2110475","article-title":"Safety of the BNT162b2 mRNA Covid-19 vaccine in a nationwide setting","author":"Barda","year":"2021","journal-title":"N Engl J Med"},{"issue":"40","key":"10.1016\/j.lanwpc.2022.100393_bib0014","doi-asserted-by":"crossref","first-page":"5729","DOI":"10.1016\/j.vaccine.2021.08.088","article-title":"Oropharyngeal shedding of herpesviruses before and after BNT162b2 mRNA vaccination against COVID-19","volume":"39","author":"Brosh-Nissimov","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.lanwpc.2022.100393_bib0015","article-title":"Real-world safety data for the Pfizer BNT162b2 SARS-CoV-2 vaccine, historical cohort study","author":"Shasha","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.lanwpc.2022.100393_bib0016","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2147\/CEOR.S229685","article-title":"The cost-effectiveness of universal varicella vaccination in Italy: a model-based assessment of vaccination strategies","volume":"12","author":"Azzari","year":"2020","journal-title":"Clinicoecon Outcomes Res"},{"issue":"3","key":"10.1016\/j.lanwpc.2022.100393_bib0017","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jinf.2016.05.008","article-title":"The burden of hospitalisation for varicella and herpes zoster in England from 2004 to 2013","volume":"73","author":"Hobbelen","year":"2016","journal-title":"J Infect"},{"issue":"5","key":"10.1016\/j.lanwpc.2022.100393_bib0018","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1177\/0141076814522033","article-title":"Risk of self-harm and suicide in people with specific psychiatric and physical disorders: comparisons between disorders using English national record linkage","volume":"107","author":"Singhal","year":"2014","journal-title":"J R Soc Med"},{"key":"10.1016\/j.lanwpc.2022.100393_bib0019","unstructured":"Census and Statistics Department. Thematic household survey report no. 58. Hong Kong, 2015."},{"key":"10.1016\/j.lanwpc.2022.100393_bib0020","article-title":"Bell's palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study","author":"Wan","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.lanwpc.2022.100393_bib0021","article-title":"Epidemiology of acute myocarditis\/pericarditis in Hong Kong adolescents following comirnaty vaccination","author":"Chua","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lanwpc.2022.100393_bib0022","article-title":"Two-dose COVID-19 vaccination and possible arthritis flare among patients with rheumatoid arthritis in Hong Kong","author":"Li","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.lanwpc.2022.100393_bib0023","doi-asserted-by":"crossref","unstructured":"Lai F, Huang L, Chui CSL, et\u00a0al. Multimorbidity and adverse events of special interest associated with CoronaVac (Sinovac) and Comirnaty (Pfizer-BioNTech). 2021.","DOI":"10.21203\/rs.3.rs-880508\/v1"},{"issue":"3","key":"10.1016\/j.lanwpc.2022.100393_bib0024","doi-asserted-by":"crossref","first-page":"362","DOI":"10.7326\/M21-3700","article-title":"Carditis following Covid-19 vaccination with messenger RNA vaccine (BNT162b2) and inactivated virus vaccine (CoronaVac): a case-control study","volume":"175","author":"Lai","year":"2022","journal-title":"Annu Intern Med"},{"issue":"11","key":"10.1016\/j.lanwpc.2022.100393_bib0025","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1001\/jama.2017.1363","article-title":"Association between dabigatran vs warfarin and risk of osteoporotic fractures among patients with nonvalvular atrial fibrillation","volume":"317","author":"Lau","year":"2017","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.lanwpc.2022.100393_bib0026","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/M19-3671","article-title":"Association between treatment with apixaban, dabigatran, rivaroxaban, or warfarin and risk for osteoporotic fractures among patients with atrial fibrillation: a population-based cohort study","volume":"173","author":"Lau","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.lanwpc.2022.100393_bib0027","doi-asserted-by":"crossref","first-page":"h6926","DOI":"10.1136\/bmj.h6926","article-title":"Cardiovascular outcomes associated with use of clarithromycin: population based study","volume":"352","author":"Wong","year":"2016","journal-title":"BMJ"},{"issue":"10","key":"10.1016\/j.lanwpc.2022.100393_bib0028","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1002\/sim.2302","article-title":"Tutorial in biostatistics: the self-controlled case series method","volume":"25","author":"Whitaker","year":"2006","journal-title":"Stat Med"},{"issue":"12","key":"10.1016\/j.lanwpc.2022.100393_bib0029","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1017\/S0950268811001531","article-title":"Use of the self-controlled case-series method in vaccine safety studies: review and recommendations for best practice","volume":"139","author":"Weldeselassie","year":"2011","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.lanwpc.2022.100393_bib0030","doi-asserted-by":"crossref","first-page":"i4515","DOI":"10.1136\/bmj.i4515","article-title":"Self controlled case series methods: an alternative to standard epidemiological study designs","volume":"354","author":"Petersen","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.lanwpc.2022.100393_bib0031","unstructured":"Ghebremichael-Weldeselassie Y. The self-controlled case series method."},{"key":"10.1016\/j.lanwpc.2022.100393_bib0034","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3389\/fpubh.2020.00361","article-title":"Do vaccines have a role as a cause of autoimmune neurological syndromes?","volume":"8","author":"Principi","year":"2020","journal-title":"Front Public Health"},{"key":"10.1016\/j.lanwpc.2022.100393_bib0035","doi-asserted-by":"crossref","first-page":"594","DOI":"10.3389\/fimmu.2019.00594","article-title":"Advances in mRNA vaccines for infectious diseases","volume":"10","author":"Zhang","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.lanwpc.2022.100393_bib0036","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3389\/fcimb.2012.00122","article-title":"Toll-like receptor sensing of human herpesvirus infection","volume":"2","author":"West","year":"2012","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"10.1016\/j.lanwpc.2022.100393_bib0037","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1016\/j.jinf.2020.04.012","article-title":"Suppressed T cell-mediated immunity in patients with COVID-19: a clinical retrospective study in Wuhan, China","volume":"81","author":"Bo","year":"2020","journal-title":"J Infect"},{"key":"10.1016\/j.lanwpc.2022.100393_bib0038","unstructured":"Census and Statistics Department. Thematic household survey report no. 58. 2015."},{"issue":"3","key":"10.1016\/j.lanwpc.2022.100393_bib0039","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1053\/j.gastro.2015.05.002","article-title":"Prevention of dabigatran-related gastrointestinal bleeding with gastroprotective agents: a population-based study","volume":"149","author":"Chan","year":"2015","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.lanwpc.2022.100393_bib0040","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1136\/gutjnl-2017-314605","article-title":"Long-term proton pump inhibitors and risk of gastric cancer development after treatment for Helicobacter pylori: a population-based study","volume":"67","author":"Cheung","year":"2018","journal-title":"Gut"}],"container-title":["The Lancet Regional Health - Western Pacific"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666606522000128?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666606522000128?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T02:37:23Z","timestamp":1763001443000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666606522000128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":38,"alternative-id":["S2666606522000128"],"URL":"https:\/\/doi.org\/10.1016\/j.lanwpc.2022.100393","relation":{},"ISSN":["2666-6065"],"issn-type":[{"value":"2666-6065","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Herpes zoster related hospitalization after inactivated (CoronaVac) and mRNA (BNT162b2) SARS-CoV-2 vaccination: A self-controlled case series and nested case-control study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Western Pacific","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanwpc.2022.100393","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100393"}}